Form 8-K - Current report:
SEC Accession No. 0001625101-22-000004
Filing Date
2022-02-08
Accepted
2022-02-08 08:58:14
Documents
13
Period of Report
2022-02-08
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K plse-20220208x8k.htm   iXBRL 8-K 75718
2 EX-99.1 plse-20220208xex99_1.htm EX-99.1 11114
  Complete submission text file 0001625101-22-000004.txt   208391

Data Files

Seq Description Document Type Size
3 EX-101.SCH plse-20220208.xsd EX-101.SCH 2769
4 EX-101.LAB plse-20220208_lab.xml EX-101.LAB 14658
5 EX-101.PRE plse-20220208_pre.xml EX-101.PRE 10499
7 EXTRACTED XBRL INSTANCE DOCUMENT plse-20220208x8k_htm.xml XML 4585
Mailing Address 3957 POINT EDEN WAY HAYWARD CA 94545
Business Address 3957 POINT EDEN WAY HAYWARD CA 94545 510-906-4600
Pulse Biosciences, Inc. (Filer) CIK: 0001625101 (see all company filings)

EIN.: 465696597 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37744 | Film No.: 22599414
SIC: 3841 Surgical & Medical Instruments & Apparatus